U.S., March 25 -- ClinicalTrials.gov registry received information related to the study (NCT07491055) titled 'Wide-Angle Tomosynthesis and AI in Diagnostic Mammography' on March 16.
Brief Summary: Breast cancer remains the most commonly diagnosed cancer and a leading cause of cancer-related mortality among women globally. Timely and accurate detection is crucial for improving prognosis and survival outcomes. While digital mammography has long served as the gold standard for screening, it is limited by overlapping tissue structures, particularly in women with dense breasts, which can obscure malignancies or create false positives.
To address these limitations, digital breast tomosynthesis (DBT), especially wide-angle DBT, has been develope...